Hepatocyte‐Derived FGF1 Alleviates Isoniazid and Rifampicin‐Induced Liver Injury by Regulating HNF4 α ‐Mediated Bile Acids Synthesis
Advanced Science · 2025
DOI: 10.1002/advs.202408688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Qian Lin und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China. Hauptthemen laut MEDLINE: Rifampin, Hepatocytes, Chemical and Drug Induced Liver Injury, Bile Acids and Salts. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Isoniazid and rifampicin co‐therapy are the main causes of anti‐tuberculosis drug‐induced liver injury (ATB‐DILI) and acute liver failure, seriously threatening human health. However, its pathophysiology is not fully elucidated. Growing evidences have shown that fibroblast growth factors (FGFs) play a critical role in diverse aspects of liver pathophysiology. The aim of this study is to investigate the role of FGFs in the pathogenesis of isoniazid (INH) and rifampicin (RIF)‐induced liver injury. Through systematic screening, this study finds that hepatic FGF1 expression is significantly downregulated in both mouse model and human patients challenged with INH and RIF. Hepatocyte‐specific Fgf1 deficiency exacerbates INH and RIF‐induced liver injury resulted from elevated bile acids (BAs) synthases and aberrant BAs accumulation. Conversely, pharmacological administration of the non‐mitogenic FGF1 analog – FGF1 ΔHBS significantly alleviated INH and RIF‐induced liver injury via restoring BAs homeostasis. Mechanically, FGF1 repressed hepatocyte nuclear factor 4 α ( Hnf4α ) transcription via activating FGF receptor 4 (FGFR4)‐ERK1/2 signaling pathway, thus reducing BAs synthase. The findings demonstrate hepatic FGF1 functions as a negative regulator of BAs biosynthesis to protect against INH and RIF‐induced liver injury via normalizing hepatic BAs homeostasis, providing novel mechanistic insights into the pathogenesis of ATB‐DILI and potential therapeutic strategies for treatment of ATB‐DILI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
- Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China.
- Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
- School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
ORCID-Profile: Jianlou Niu
Förderung
- Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Lin, Q., Zhang, J., Qi, J., Tong, J., Chen, S., Zhang, S., Liu, X., Lou, H., Lv, J., Lin, R., Xie, J., Jin, Y., Wang, Y., Ying, L., Wu, J., & Niu, J. (2025). Hepatocyte‐Derived FGF1 Alleviates Isoniazid and Rifampicin‐Induced Liver Injury by Regulating HNF4 α ‐Mediated Bile Acids Synthesis. Advanced Science. https://doi.org/10.1002/advs.202408688
Vancouver
Lin Q, Zhang J, Qi J, Tong J, Chen S, Zhang S, et al. Hepatocyte‐Derived FGF1 Alleviates Isoniazid and Rifampicin‐Induced Liver Injury by Regulating HNF4 α ‐Mediated Bile Acids Synthesis. Advanced Science. 2025. doi:10.1002/advs.202408688
BibTeX
@article{Lin2025,
author = {Lin, Qian and Zhang, Jiaren and Qi, Jie and Tong, Jialin and Chen, Shenghuan and Zhang, Sudan and Liu, Xingru and Lou, Huatong and Lv, Jiaxuan and Lin, Ruoyu and Xie, Junjun and Jin, Yi and Wang, Yang and Ying, Lei and Wu, Jiamin and Niu, Jianlou},
title = {Hepatocyte‐Derived FGF1 Alleviates Isoniazid and Rifampicin‐Induced Liver Injury by Regulating HNF4 α ‐Mediated Bile Acids Synthesis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202408688}
}
EUVIMED